CD133+ glioma cancer-initiating/stem-like cells are able to suppress immune responses against the tumor by inhibiting T-cell effector activity and stimulating that of T-cell suppressor cells (Tregs) (83). This evidence concerns the gene PROM1 and neoplasm.